Oklahoma
Disorders Screened in Oklahoma
Oklahoma does NOT provide the full panel of screenings recommended by Save Babies Through Screening Foundation. Parents should seek supplemental screening for the disorders and conditions not included in the state's panel.
The disorders that are screened, or likely to be detected, by your state's program are identified by the National Newborn Screening and Genetics Resource Center in simplified format or in PDF format.
If you have trouble with the PDF file, then
Download the FREE version of Adobe Reader.
General Information
Oklahoma began screening for MCAD Deficiency (MCADD) on June 5, 2006. Future plans include the addition of other metabolic disorders that can be detected using tandem mass spectrometry. Oklahoma had added Congenital Adrenal Hyperplasia (CAH) and Cystic Fibrosis (CF) to its newborn screening panel on February 14, 2005.
Background: According to a
press release from the Oklahoma House of Representatives on June 13,
2002, Governor Frank Keating signed into law a bill which gives the State Health
Department authority to provide a comprehensive newborn screening program for
early treatment of genetic, metabolic and biochemical disorders. The program
will provide information about the nature of the disorders, examinations for the
detection of the diseases in infancy and follow-up measures to prevent the
diseases from ultimately claiming lives.
The new law did
not include funding, but it paved the way for the Department of Health to expand
newborn screening beyond the former law which allowed testing for inborn
metabolic diseases only for the prevention of mental retardation. SB 1608
authorized screening for diseases outside that category and identified the
prevention of infant mortality as an objective.
Under the 2002
law, by Sen. Bernest Cain, D-Oklahoma City, the screening program was able
to start testing for additional conditions. Pam King, state genetics
coordinator for the Department of Health, said three disorders under
consideration at that time were cystic fibrosis, a multisystem disease which is the primary
genetic killer of children and young adults; congenital adrenal hyperplasia,
characterized by a defect in steroid hormone production that can cause incorrect
sex assignment or death; and MCADD, a genetic disorder that can lead to seizures,
cardiac arrest and death.
According to the state Health Department, the 2002 newborn screening
program costs were about $22 per test. Part of the cost of the program was recovered
through a $10.50 fee charged to hospitals or physicians for each blood
collection kit. Increased costs due to the expanded screening had not been
determined as of the 2002 press release.
Newborn Screening Advisory Committee
Oklahoma has a
Newborn Screening Advisory Committee (NBSAC).
Oklahoma NBSAC Chairperson
Unknown at this time
NBSAC Meeting Dates
Unknown at this time
Location of Meetings:
Unknown at this time
More Information and Support Resources
Please write to us if you have any updates, changes, or new information to be added to this page.
HOME | ABOUT US | PRESS RELEASES | DONATE NOW | VOLUNTEER NOW
Contact
Save Babies Through Screening
for questions about the content of this site or
the Webmaster
for questions about technical issues related to this site.
Terms of use
for this site.